Zhang Rui, Chen Ling, Cui Ya-Deng, Li Ge
School of Public Health and Management, Research Center for Medicine and Social Development, Chongqing Medical University, Chongqing, 400016, China.
Collaborative Innovation Center of Social Risk Governance in Health, Chongqing Medical University, Chongqing, 400016, China.
Iran J Public Health. 2019 Jan;48(1):1-8.
The aim of our study was to identify the association between Human papillomavirus (HPV) positive rate and smoking in lung cancer (LC) patients. Meanwhile, to analyze differences among gender, age differences on HPV infection rate in LC patients.
We performed a systematic literature search through PubMed, Wan Fang, China National Knowledge Infrastructure (CNKI), MEDLINE, EMBASE (OVID), and Web of Science databases from 1991-2017, and we searched these keywords such as "lung cancer", "HPV", "smoking", and "human papillomavirus". Review Manager 5.3 software was used to analyze. An estimate of the odds ratio (OR) with 95% confidence intervals (CI) was calculated.
In China, a statistical significance was observed between HPV positive rate and smoking in LC patients (OR=2.34, 95%CI: 1.76-3.09, <0.001; I =25%). However, after stratified by region, no significance was observed in other regions, gender, and age.
HPV infections are associated with smoking in LC patients. The association between HPV infection and smoking in LC patients may relate to different regions. There were no differences between gender and age among HPV infection rates in LC patients. To identify the etiology of smoking, HPV, and LC, a further experimental research needs to be conducted.
我们研究的目的是确定肺癌(LC)患者中人类乳头瘤病毒(HPV)阳性率与吸烟之间的关联。同时,分析LC患者中HPV感染率在性别、年龄上的差异。
我们通过PubMed、万方、中国知网(CNKI)、MEDLINE、EMBASE(OVID)和科学网数据库对1991年至2017年的文献进行了系统检索,并检索了“肺癌”、“HPV”、“吸烟”和“人类乳头瘤病毒”等关键词。使用Review Manager 5.3软件进行分析。计算了比值比(OR)及95%置信区间(CI)的估计值。
在中国,LC患者中HPV阳性率与吸烟之间存在统计学意义(OR=2.34,95%CI:1.76-3.09,<0.001;I=25%)。然而,按地区分层后,在其他地区、性别和年龄方面未观察到显著差异。
LC患者中HPV感染与吸烟有关。LC患者中HPV感染与吸烟之间的关联可能与不同地区有关。LC患者中HPV感染率在性别和年龄上没有差异。为了确定吸烟、HPV和LC的病因,需要进行进一步的实验研究。